Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$705K Buy
5,079
+3,414
+205% +$429K 0.02% 268
2023
Q4
$207K Buy
+1,665
New +$170K ﹤0.01% 481
2023
Q3
Sell
-1,600
Closed -$206K 491
2023
Q2
$206K Buy
+1,600
New +$194K ﹤0.01% 433

Other funds holding DXCM

Connectus Wealth's DXCM Position: Q1 2024 in Review

Connectus Wealth increased its DexCom (DXCM) stake by 205% in Q1 2024, buying an estimated $429K and bringing the position to 5,079 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #268.

Connectus Wealth first reported a position in DXCM in Q2 2023 and has held it in 3 quarters since. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Connectus Wealth held 5,079 shares of DexCom worth $705K as of Q1 2024.
  • Connectus Wealth bought 3,414 DexCom shares in Q1 2024, an estimated $429K.
  • DexCom made up 0.02% of Connectus Wealth's portfolio in Q1 2024, its #268 holding.
  • Connectus Wealth first reported a position in DexCom in Q2 2023 and has held it in 3 quarters since.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.